Ken Fisher
TNGX icon

Ken Fisher’s Tango Therapeutics TNGX Stock Holding History

Ken Fisher’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.4M Sell
162,399
-25,294
-13% -$352K ﹤0.01% 504
2025
Q4 		$1.66M Sell
187,693
-22,659
-11% -$195K ﹤0.01% 588
2025
Q3 		$1.77M Sell
210,352
-13,725
-6% -$92.9K ﹤0.01% 596
2025
Q2 		$1.15M Hold
224,077
– – ﹤0.01% 679
2025
Q1 		$307K Buy
224,077
+69,130
+45% +$170K ﹤0.01% 890
2024
Q4 		$479K Hold
154,947
– – ﹤0.01% 779
2024
Q3 		$1.19M Hold
154,947
– – ﹤0.01% 642
2024
Q2 		$1.33M Buy
154,947
+54,256
+54% +$419K ﹤0.01% 639
2024
Q1 		$799K Hold
100,691
– – ﹤0.01% 706
2023
Q4 		$997K Buy
+100,691
New +$874K ﹤0.01% 692

Other funds holding TNGX

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Ken Fisher's TNGX Position: Q1 2026 in Review

Ken Fisher reduced its Tango Therapeutics (TNGX) stake by 13% in Q1 2026, selling an estimated $352K and leaving 162,399 shares worth $3.4M. The position accounts for ﹤0.01% of the portfolio, ranked #504.

Ken Fisher first reported a position in TNGX in Q4 2023 and has held it in 10 quarters since. 194 funds tracked by Wall St. Rank hold TNGX as of Q1 2026.

  • Ken Fisher held 162,399 shares of Tango Therapeutics worth $3.4M as of Q1 2026.
  • Ken Fisher sold 25,294 Tango Therapeutics shares in Q1 2026, an estimated $352K.
  • Tango Therapeutics made up ﹤0.01% of Ken Fisher's portfolio in Q1 2026, its #504 holding.
  • Ken Fisher first reported a position in Tango Therapeutics in Q4 2023 and has held it in 10 quarters since.
  • 194 funds tracked by Wall St. Rank held Tango Therapeutics as of Q1 2026.

Based on Fisher Asset Management's 13F filing for Q1 2026, filed 5 May 2026.